# Treatment of Mitral Regurgitation Using a Minimally Invasive Approach With the HARPOON Device.

> **NCT04382612** · NA · TERMINATED · sponsor: **Edwards Lifesciences** · enrollment: 42 (actual)

## Conditions studied

- Mitral Regurgitation

## Interventions

- **DEVICE:** HARPOON Beating Heart Mitral Valve Repair System (MVRS)

## Key facts

- **NCT ID:** NCT04382612
- **Lead sponsor:** Edwards Lifesciences
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2020-10-02
- **Primary completion:** 2022-11-14
- **Final completion:** 2022-12-01
- **Target enrollment:** 42 (ACTUAL)
- **Why stopped:** Low enrollment
- **Last updated:** 2023-12-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04382612

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04382612, "Treatment of Mitral Regurgitation Using a Minimally Invasive Approach With the HARPOON Device.". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT04382612. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*